AbbVie Inc. is 287.7x more valuable than ATAI Life Sciences N.V. by market capitalization ($397.12 B vs $1.38 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ATAI | ABBV |
|---|---|---|
| Market cap | $1.38 B | $397.12 B |
| US-listed rank | #2408 | #30 |
| Revenue (latest FY) | $308.00K | $61.16B |
| Net income (latest FY) | -$149.27M | $4.23B |
| Net margin | -48464.0% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 320 | 1,008 |
AbbVie Inc. is 287.7x more valuable than ATAI Life Sciences N.V. by market capitalization ($397.12 B vs $1.38 B).
In their latest fiscal years, ATAI Life Sciences N.V. reported $308.00K in revenue while AbbVie Inc. reported $61.16B.
Full pages: ATAI Life Sciences N.V. and AbbVie Inc., or browse the full rankings.